We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABTC
12726
American Bitcoin Corp
ABTC
$471M
$46K ﹤0.01%
1
PVLA
12727
PUT
Palvella Therapeutics
PVLA
$2.27B
$46K ﹤0.01%
191
+32
+20% +$8.41K
PSTX
12728
CALL
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$46K ﹤0.01%
+10,200
New +$46K
AUMN
12729
DELISTED
Golden Minerals Company
AUMN
$46K ﹤0.01%
3,690
+3,096
+521% +$35.1K
BHIL
12730
PUT
DELISTED
Benson Hill, Inc.
BHIL
$46K ﹤0.01%
+409
New +$56.6K
SCPX
12731
PUT
DELISTED
Scorpius Holdings, Inc.
SCPX
$46K ﹤0.01%
4
+1
+33% +$11.1K
VAXX
12732
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$46K ﹤0.01%
+10,766
New +$59.5K
OTIC
12733
DELISTED
Otonomy, Inc.
OTIC
$46K ﹤0.01%
+19,038
New +$40.5K
FCAX.WS
12734
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$46K ﹤0.01%
115,762
+1,081
+0.9% +$607
ACII.WS
12735
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$46K ﹤0.01%
139,816
+1,201
+0.9% +$533
MACC.WS
12736
DELISTED
Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
MACC.WS
$46K ﹤0.01%
203,500
+36,426
+22% +$12.1K
BBAR icon
12737
PUT
BBVA Argentina
BBAR
$3.49B
$45K ﹤0.01%
12,800
-16,800
-57% -$54.7K
BKYI
12738
BIO-key International
BKYI
$4.38M
$45K ﹤0.01%
103
-22
-18% -$8.89K
BORR
12739
Borr Drilling
BORR
$1.19B
$45K ﹤0.01%
13,364
-25,725
-66% -$65.7K
GTBP icon
12740
PUT
GT Biopharma
GTBP
$11.5M
$45K ﹤0.01%
517
-76
-13% -$6.7K
LCFY icon
12741
Locafy
LCFY
$4.28M
$45K ﹤0.01%
+952
New +$57.5K
LX
12742
CALL
LexinFintech Holdings
LX
$241M
$45K ﹤0.01%
17,200
-6,800
-28% -$22.5K
PRPO icon
12743
CALL
Precipio
PRPO
$42.8M
$45K ﹤0.01%
+1,670
New +$46.4K
OLOX
12744
PUT
Olenox Industries
OLOX
$4.5M
$45K ﹤0.01%
4
-4
-50% -$46.2K
TK icon
12745
CALL
Teekay
TK
$985M
$45K ﹤0.01%
14,200
-61,900
-81% -$200K
XBIO icon
12746
PUT
Xenetic Biosciences
XBIO
$7.26M
$45K ﹤0.01%
4,450
-1,520
-25% -$15.9K
KYCHR
12747
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$45K ﹤0.01%
+322,000
New +$58K
BCEL
12748
PUT
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$45K ﹤0.01%
14,200
-8,400
-37% -$20.4K
OTMO
12749
CALL
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$45K ﹤0.01%
1,513
-3,027
-67% -$101K
SEAC
12750
PUT
DELISTED
Seachange International Inc
SEAC
$45K ﹤0.01%
1,995
-870
-30% -$22K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.